The study of Alzheimer's has led to an increased understanding of the multiple pathologies and pathways of the disease. As such, it has been proposed that Alzheimer's disease and its' various stages might be most effectively treated with a combination approach rather than a single therapy; however, combination approaches present many challenges, including: limitations of non clinical models, complexity of clinical trial design, and unclear regulatory requirements.

This AARR topic meeting will provide a forum to discuss the approaches and challenges of combination therapy for AD. It will also allow experts in the field (academia, industry, and government) to provide perspectives that may help establish a path forward for the development of new combination therapies.

Please RSVP below.